Education
About Us
Working with TipRanks
Follow Us
Stoke Therapeutics (STOK)
:STOK
STOK Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
STOK Stock 12 Month Forecast
Average Price Target
$27.20
▲(101.33%Upside)
| Highest Price Target$35.00 | Average Price Target$27.20 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$15.5
Buy
14.73%
Upside
Reiterated
07/23/25
Stoke Therapeutics' overall score is driven by strong technical indicators and a significant corporate event that enhances its market prospects. Financial performance is solid, with notable improvements in profitability and cash flow. Valuation is fair, but the absence of a dividend yield may limit appeal. The lack of earnings call data is neutral in this assessment.
Jefferies
$30
Buy
122.06%
Upside
Initiated
07/18/25
H.C. Wainwright
$35
Buy
159.07%
Upside
Reiterated
07/11/25
Leerink Partners
―
Buy
―
Reiterated
07/10/25
Canaccord Genuity
$20
Buy
48.04%
Upside
Reiterated
07/10/25
Needham
$22
Buy
62.84%
Upside
Reiterated
07/01/25
TD Cowen
―
Buy
―
Reiterated
05/13/25
BTIG
$29
Buy
114.66%
Upside
Reiterated
05/13/25
Chardan Capital
$24
Buy
77.65%
Upside
Reiterated
03/19/25
J.P. Morgan
$15
Hold
11.03%
Upside
Reiterated
11/06/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$15.5
Buy
14.73%
Upside
Reiterated
07/23/25
Stoke Therapeutics' overall score is driven by strong technical indicators and a significant corporate event that enhances its market prospects. Financial performance is solid, with notable improvements in profitability and cash flow. Valuation is fair, but the absence of a dividend yield may limit appeal. The lack of earnings call data is neutral in this assessment.
Jefferies
$30
Buy
122.06%
Upside
Initiated
07/18/25
H.C. Wainwright
$35
Buy
159.07%
Upside
Reiterated
07/11/25
Leerink Partners
―
Buy
―
Reiterated
07/10/25
Canaccord Genuity
$20
Buy
48.04%
Upside
Reiterated
07/10/25
Needham
$22
Buy
62.84%
Upside
Reiterated
07/01/25
TD Cowen
―
Buy
―
Reiterated
05/13/25
BTIG
$29
Buy
114.66%
Upside
Reiterated
05/13/25
Chardan Capital
$24
Buy
77.65%
Upside
Reiterated
03/19/25
J.P. Morgan
$15
Hold
11.03%
Upside
Reiterated
11/06/24
Best Analysts Covering Stoke Therapeutics
1 Month
xxx
Success Rate
18/34 ratings generated profit
Average Return
+0.26%
reiterated a xxx
rating 25 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.94% of your transactions generating a profit, with an average return of +0.26% per trade.
3 Months
xxx
Success Rate
7/13 ratings generated profit
Average Return
+4.13%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +4.13% per trade.
1 Year
Success Rate
13/22 ratings generated profit
Average Return
+37.22%
reiterated a buy rating 2 months ago
Copying Thomas Shrader's trades and holding each position for 1 Year would result in 59.09% of your transactions generating a profit, with an average return of +37.22% per trade.
2 Years
xxx
Success Rate
13/16 ratings generated profit
Average Return
+46.19%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 81.25% of your transactions generating a profit, with an average return of +46.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
STOK Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
12
10
11
6
9
Buy
6
3
3
3
6
Hold
0
0
3
4
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
13
17
13
19
Each month's total comprises the sum of three months' worth of ratings.
STOK Financial Forecast
STOK Stock Forecast FAQ
What is STOK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stoke Therapeutics’s 12-month average price target is 27.20.
What is STOK’s upside potential, based on the analysts’ average price target?
Stoke Therapeutics has 101.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is STOK a Buy, Sell or Hold?
Stoke Therapeutics has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Stoke Therapeutics’s price target?
The average price target for Stoke Therapeutics is 27.20. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $20.00. The average price target represents 101.33% Increase from the current price of $13.51.
The highest analyst price target is $35.00 ,the lowest forecast is $20.00. The average price target represents 101.33% Increase from the current price of $13.51.
What do analysts say about Stoke Therapeutics?
Stoke Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of STOK?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.